HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hanns-Ulrich Marschall Selected Research

Cholestyramine Resin (Questran)

8/2011Nutritional regulation of bile acid metabolism is associated with improved pathological characteristics of the metabolic syndrome.
12/2006Analysis of ileal sodium/bile acid cotransporter and related nuclear receptor genes in a family with multiple cases of idiopathic bile acid malabsorption.
4/2003Intrahepatic Cholestasis of Pregnancy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hanns-Ulrich Marschall Research Topics

Disease

22Intrahepatic Cholestasis of Pregnancy
11/2021 - 08/2004
22Cholestasis
01/2021 - 12/2002
20Fibrosis (Cirrhosis)
01/2022 - 02/2006
19Non-alcoholic Fatty Liver Disease
01/2022 - 09/2013
17Liver Diseases (Liver Disease)
01/2022 - 12/2002
16Sclerosing Cholangitis
01/2022 - 07/2004
14Pruritus (Itching)
01/2022 - 04/2003
14Inflammation (Inflammations)
01/2022 - 02/2006
9Insulin Resistance
09/2021 - 01/2011
6Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
01/2020 - 04/2015
5Stillbirth
01/2021 - 03/2013
5Dyslipidemias (Dyslipidemia)
01/2020 - 01/2011
4Neoplasms (Cancer)
01/2022 - 06/2014
4Fatty Liver
01/2022 - 01/2011
4Metabolic Diseases (Metabolic Disease)
01/2020 - 01/2017
3Body Weight (Weight, Body)
06/2022 - 11/2005
3Gestational Diabetes (Gestational Diabetes Mellitus)
01/2022 - 01/2019
3Obesity
01/2021 - 08/2011
3Gallstones (Gallstone)
11/2019 - 05/2010
3Type 2 Diabetes Mellitus (MODY)
01/2019 - 09/2013
3Diarrhea
01/2018 - 12/2006
3Liver Cirrhosis (Hepatic Cirrhosis)
01/2017 - 09/2013
3Weight Loss (Weight Reduction)
01/2016 - 09/2013
3Infarction (Infarctions)
02/2006 - 10/2002
2Intrahepatic Cholestasis
01/2022 - 01/2019
2Hyperglycemia
01/2022 - 01/2018
2Alcoholic Fatty Liver
01/2022 - 01/2018
2Autoimmune Hepatitis
01/2022 - 12/2017
2Premature Birth (Birth, Premature)
01/2021 - 01/2019
2Cholangitis
01/2020 - 02/2006
2Glucose Intolerance
01/2020 - 01/2018
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2020 - 01/2020
2Disease Progression
01/2018 - 07/2010
2Bile Duct Diseases (Bile Duct Disease)
01/2018 - 01/2017
2Hyperinsulinism (Hyperinsulinemia)
01/2018 - 03/2008
2Digestive System Diseases
01/2018 - 10/2013
2Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2016 - 08/2011
2Cholelithiasis
07/2013 - 08/2004
1Ventricular Dysfunction
01/2021
1Smith-Lemli-Opitz Syndrome
01/2021
1Diabetic Nephropathies (Diabetic Nephropathy)
12/2020

Drug/Important Bio-Agent (IBA)

51Bile Acids and Salts (Bile Acids)IBA
06/2022 - 12/2002
29Ursodeoxycholic Acid (Urso)FDA LinkGeneric
11/2021 - 10/2002
16LipidsIBA
01/2022 - 05/2010
8Proteins (Proteins, Gene)FDA Link
07/2021 - 02/2006
8obeticholic acidIBA
01/2020 - 09/2013
7Glucose (Dextrose)FDA LinkGeneric
06/2022 - 01/2011
6ProgesteroneFDA LinkGeneric
01/2022 - 02/2008
6Rifampin (Rifampicin)FDA LinkGeneric
11/2021 - 08/2005
6CholesterolIBA
01/2021 - 05/2010
5Pharmaceutical PreparationsIBA
01/2022 - 07/2017
5Messenger RNA (mRNA)IBA
01/2022 - 03/2016
5AcidsIBA
09/2021 - 06/2009
5Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
01/2020 - 07/2017
4Protein Kinases (Protein Kinase)IBA
12/2021 - 01/2019
4Biomarkers (Surrogate Marker)IBA
01/2021 - 08/2005
4Alanine Transaminase (SGPT)IBA
01/2019 - 09/2013
4BilirubinIBA
08/2016 - 04/2003
3Phosphotransferases (Kinase)IBA
01/2022 - 01/2021
3Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
10/2021 - 05/2006
3Antisense OligonucleotidesIBA
01/2021 - 01/2018
3LigandsIBA
01/2020 - 08/2005
3Cholic AcidIBA
01/2020 - 08/2011
3Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
11/2019 - 09/2013
3Transaminases (Aminotransferases)IBA
01/2019 - 04/2003
3Alkaline PhosphataseIBA
08/2016 - 04/2015
3EnzymesIBA
09/2013 - 08/2005
3Cholestyramine Resin (Questran)FDA LinkGeneric
08/2011 - 04/2003
3Dexamethasone (Maxidex)FDA LinkGeneric
02/2008 - 04/2003
2Sulfates (Sulfates, Inorganic)IBA
01/2022 - 04/2016
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2020 - 03/2006
2Triglycerides (Triacylglycerol)IBA
10/2019 - 08/2011
2Glucagon-Like Peptide 1 (GLP 1)IBA
01/2019 - 01/2016
2Therapeutic UsesIBA
01/2018 - 06/2009
2ORALIT (ORS)IBA
02/2017 - 10/2013
2Glycine (Aminoacetic Acid)FDA LinkGeneric
01/2017 - 11/2013
2Indicators and Reagents (Reagents)IBA
04/2016 - 11/2010
2Fatty Acids (Saturated Fatty Acids)IBA
06/2015 - 03/2008
2Insulin (Novolin)FDA Link
11/2013 - 09/2013
224-norursodeoxycholic acidIBA
06/2009 - 02/2006
2Glutathione (Reduced Glutathione)IBA
08/2007 - 12/2002
1oligofructoseIBA
06/2022
1Carrier Proteins (Binding Protein)IBA
01/2022
1tetrahydrobenzo-4,6-dimethylangelicinIBA
01/2022
1Leucine (L-Leucine)FDA Link
09/2021
1Valine (L-Valine)FDA Link
09/2021
1Branched-Chain Amino AcidsIBA
09/2021
1CreatineIBA
09/2021
1TabletsIBA
01/2021
1Anti-Bacterial Agents (Antibiotics)IBA
01/2021
17-dehydrocholesterolIBA
01/2021
1pro-brain natriuretic peptide (1-76)IBA
01/2021
1Choline (Choline Chloride)IBA
01/2020
1Tumor Necrosis Factor InhibitorsIBA
01/2020
1Methionine (L-Methionine)FDA Link
01/2020
1Member 11 Subfamily B ATP Binding Cassette TransporterIBA
01/2020

Therapy/Procedure

14Therapeutics
01/2022 - 02/2006
7Liver Transplantation
01/2022 - 07/2010
3Ligation
01/2017 - 01/2017
2Bariatric Surgery
01/2016 - 01/2011